This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80415416
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu n'ochobre de 2006 im Oktober 2006 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 October 2006 article scientifique publié en 2006 wetenschappelijk artikel наукова стаття, опублікована в жовтні 2006
p:P577
wds:Q80415416-253B7E9D-036A-4B3A-870A-9C5666A82814
wdt:P577
2006-10-01T00:00:00Z
p:P2093
wds:Q80415416-F78E5850-131D-4E3E-B9BB-0DC100188863 wds:Q80415416-C06A7B42-CA4D-4E29-A8EA-EC12E3EB6890 wds:Q80415416-940C787D-F4E3-4EC9-B69A-AA575F56AD1D wds:Q80415416-3AB7B62F-61D3-4889-8B23-843F4A1C6858
wdt:P2093
Misael Uribe Esquivel Javier Lizardi-Cervera Dra Ivonne Becerra Laparra Martha E Ramos Ostos
rdfs:label
[Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects] [Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects]
skos:prefLabel
[Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects] [Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects]
schema:name
[Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects] [Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects]
p:P50
wds:Q80415416-F2077EDE-5BDA-4769-9660-2F8D1139D9D2
wdt:P50
wd:Q76343835
p:P1476
wds:Q80415416-54E9C271-A419-4F78-90DD-39B09D1B3EB2
wdt:P1476
[Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects]
p:P304
wds:Q80415416-344A7008-23B3-4E6C-B47B-BC6C4A2F87AB
wdt:P304
453-459
p:P31
wds:Q80415416-C36EB630-EE7B-4FF6-8786-CD28E4033D38
wdt:P31
wd:Q13442814
p:P921
wds:Q80415416-28B7AA5B-5E70-42AA-A2B5-A28F48A602A3
wdt:P921
wd:Q657193
p:P698
wds:Q80415416-8CCC52F2-BC42-4759-A640-90F2AAB0D1D4
wdtn:P698
n9:17542278
wdt:P698
17542278
p:P1433
wds:Q80415416-49790D07-FEA1-4B28-A64E-338EA72BDD75
wdt:P1433
wd:Q26867052
p:P433
wds:Q80415416-FC024C22-D2C6-4812-B246-FB647073EE33
p:P478
wds:Q80415416-4CB6C815-1857-4915-80B3-C2B04828409B
wdt:P433
4
wdt:P478
71